BiotechTube

AZD1446 + AZD1446 + AZD1446 + Placebo

Phase 2Completed
0 watching 0 views this week⚡ Active
52
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Adult ADHD

Conditions

Adult ADHD

Trial Timeline

Nov 1, 2009 → Aug 1, 2010

NCT ID
NCT01012375

About AZD1446 + AZD1446 + AZD1446 + Placebo

AZD1446 + AZD1446 + AZD1446 + Placebo is a phase 2 stage product being developed by AstraZeneca for Adult ADHD. The current trial status is completed. This product is registered under clinical trial identifier NCT01012375. Target conditions include Adult ADHD.

Hype Score Breakdown

Clinical
17
Activity
12
Company
10
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT01012375Phase 2Completed

Competing Products

20 competing products in Adult ADHD

See all competitors
ProductCompanyStageHype Score
BBP-398 + sotorasibBridgeBio PharmaPhase 1
30
Daridorexant + PlaceboIdorsiaPhase 1
28
SON-1010 (IL12-FHAB)Sonnet BioTherapeuticsPhase 1
28
SomatropinEli LillyPhase 3
77
agenT-797MiNK TherapeuticsPhase 1
25
PegilodecakinEli LillyPhase 1
33
eFT226 + Sotorasib + Fulvestrant + Abemaciclib + TrastuzumabeFFECTOR TherapeuticsPhase 1/2
33
Lazertinib(G001) + Lazertinib(G002)YuhanPhase 1
33
Patritumab deruxtecanDaiichi SankyoPhase 2
52
DJ-927 + capecitabineDaiichi SankyoPhase 1
33
Valemetostat TosylateDaiichi SankyoPhase 2
52
RoxadustatAstellas PharmaPhase 1
33
ASP3325 + PlaceboAstellas PharmaPhase 1
33
TRK-100STPAstellas PharmaPhase 1
33
EnsitrelvirShionogiPhase 1
33
E6130 + PlaceboEisaiPhase 1
33
E7389 + E7389 + E7389EisaiPhase 1
33
Eribulin MesylateEisaiPhase 1
33
E2022 + E2022 + E2022 + E2022 + E2022EisaiPhase 1
33
Donepezil Hydrochloride + Donepezil Hydrochloride + Donepezil Hydrochloride + Donepezil HydrochlorideEisaiPhase 1
33

Other Products from AstraZeneca

QuetiapineApproved
85
Dapagliflozin 5 mg + Placebo tabletApproved
85
QuetiapineApproved
85
Ticagrelor + ClopidogrelApproved
85
DurvalumabApproved
85